LRI Investments LLC Lowers Stock Position in The Cooper Companies, Inc. $COO

LRI Investments LLC cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 50.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 776 shares of the medical device company’s stock after selling 803 shares during the period. LRI Investments LLC’s holdings in Cooper Companies were worth $55,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its position in shares of Cooper Companies by 3.4% during the 1st quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company’s stock valued at $436,681,000 after purchasing an additional 172,485 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of Cooper Companies by 17.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock valued at $399,340,000 after purchasing an additional 686,751 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Cooper Companies by 12.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company’s stock valued at $333,595,000 after purchasing an additional 425,400 shares during the last quarter. Millennium Management LLC increased its position in shares of Cooper Companies by 36.0% during the 1st quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company’s stock valued at $217,405,000 after purchasing an additional 682,166 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Cooper Companies by 15.5% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,121,835 shares of the medical device company’s stock valued at $178,977,000 after purchasing an additional 284,943 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of COO stock opened at $69.30 on Tuesday. The Cooper Companies, Inc. has a twelve month low of $61.78 and a twelve month high of $109.37. The stock has a market capitalization of $13.78 billion, a price-to-earnings ratio of 34.14, a P/E/G ratio of 1.79 and a beta of 1.02. The stock has a fifty day simple moving average of $69.39 and a two-hundred day simple moving average of $73.48. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.06 billion. During the same period in the prior year, the business earned $0.96 EPS. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its Board of Directors has authorized a share repurchase program on Wednesday, September 17th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the medical device company to repurchase up to 15.4% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on COO shares. UBS Group raised Cooper Companies to a “buy” rating in a research report on Tuesday, June 17th. Mizuho cut their price objective on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 16th. Morgan Stanley set a $76.00 price objective on Cooper Companies and gave the company an “equal weight” rating in a research report on Thursday, August 28th. Piper Sandler cut their price objective on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating on the stock in a research report on Thursday, August 28th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price objective on shares of Cooper Companies in a research report on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus target price of $84.77.

Insider Activity

In related news, CEO Albert G. White III acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The stock was purchased at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the purchase, the chief executive officer directly owned 226,151 shares of the company’s stock, valued at $15,466,466.89. This trade represents a 4.63% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Brian G. Andrews acquired 1,525 shares of the firm’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were bought at an average price of $65.68 per share, with a total value of $100,162.00. Following the completion of the purchase, the executive vice president directly owned 22,191 shares in the company, valued at $1,457,504.88. The trade was a 7.38% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 17,975 shares of company stock worth $1,216,346 over the last ninety days. 1.98% of the stock is currently owned by corporate insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.